34 Recruiting Waldenstrom Macroglobulinemia Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Waldenstrom Macroglobulinemia
Related Conditions
Top Recruiting Waldenstrom Macroglobulinemia Studies
Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom
📍 Cellectar Biosciences site — Los Angeles, California
View Study & Checklist ➔Pirtobrutinib and Venetoclax in Waldenström Macroglobulinemia
📍 Beth Israel Deaconness Medical — Boston, Massachusetts
View Study & Checklist ➔Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔A Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenström Macroglobulinemia
📍 City of Hope National Medical Center — Duarte, California
View Study & Checklist ➔Bendamustine, Rituximab and Acalabrutinib in Waldenstrom's Macroglobulinemia
📍 Tom Baker Cancer Centre — Calgary, Alberta
View Study & Checklist ➔Ibrutinib + Venetoclax in Untreated WM
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔Loncastuximab Tesirine in WM
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔Mosunetuzumab in Combination With Pirtobrutinib in Patients With Relapsed or Refractory Waldenstrom Macroglobulinemia (MPOWER)
📍 Huntsman Cancer Institute at University of Utah — Salt Lake City, Utah
View Study & Checklist ➔Epcoritamab in Previously Treated WM
📍 Beth Israel Deaconess Medical Center — Boston, Massachusetts
View Study & Checklist ➔Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia
📍 Clearview Cancer Institute — Huntsville, Alabama
View Study & Checklist ➔Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM
📍 Colorado Blood Cancer Institute (CBCI) — Denver, Colorado
View Study & Checklist ➔A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)
📍 Dana Farber Cancer Institute (Data Collection and Specimen Analysis) — Boston, Massachusetts
View Study & Checklist ➔Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔